Your browser doesn't support javascript.
loading
Prognostic Evaluation of the Site of Invasion in Pathological Stage T3a Renal Cell Carcinoma.
Lai, Gu-Shun; Li, Jian-Ri; Wang, Shian-Shiang; Chen, Chuan-Shu; Yang, Chun-Kuang; Hung, Sheng-Chun; Cheng, Chen-Li; Ou, Yen-Chuan; Chiu, Kun-Yuan.
Affiliation
  • Lai GS; Division of Urology, Department of Surgery, Chiayi Branch, Taichung Veterans General Hospital, Chiayi, Taiwan, R.O.C.
  • Li JR; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Wang SS; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
  • Chen CS; Department of Medicine and Nursing, Hungkuang University, Taichung, Taiwan, R.O.C.
  • Yang CK; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Hung SC; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
  • Cheng CL; Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan, R.O.C.
  • Ou YC; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
  • Chiu KY; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
In Vivo ; 35(2): 1083-1089, 2021.
Article in En | MEDLINE | ID: mdl-33622905
ABSTRACT
BACKGROUND/

AIM:

To investigate the prognostic values of fat invasion (FI) and renal vein invasion (RVI) in pT3a renal cell carcinoma (RCC), as single factors or concomitant presence. PATIENTS AND

METHODS:

We retrospectively reviewed the data of 173 patients who underwent radical or partial nephrectomy for RCC in our Institution.

RESULTS:

At a median follow-up time of 48 months, patients with RVI showed significantly increased risk of disease recurrence and worse cancer-specific survival (CSS) when compared to those with FI (p=0.007, p=0.022, respectively). Having combined RVI and FI did not show inferior prognosis compared to those with RVI only. In multivariable analysis, RVI was an independent factor for disease recurrence (HR=2.06, 95% CI=1.10-3.87, p=0.024) and CSS (HR=2.46, 95% CI=1.01-6.0, p=0.048).

CONCLUSION:

For patients with T3a renal tumors, RVI was associated with inferior prognosis compared to those with FI.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: In Vivo Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: GR / GRECIA / GREECE / GRÉCIA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: In Vivo Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: GR / GRECIA / GREECE / GRÉCIA